The FDA’s authorization of COVID-19 shots for children ages 6 months to 4 years will bring relief for millions of parents. Pending CDC endorsement, shots for this group will be available within days.
The COVID-19 pandemic has seen an increase in wastewater testing to monitor the spread of the virus. But historical cases show that targeted surveillance can further marginalize vulnerable populations.
Ronald Labonte, L’Université d’Ottawa/University of Ottawa
Waiving patent rights on COVID-19 vaccines and drugs is still crucial to ensure access globally, but the waiver on the table at the June World Trade Organization meeting doesn’t do the job.
The COVID-19 vaccines continue to be effective against severe illness leading to hospitalization and death in all age groups, including children ages 5 to 11.
Scientists are working on intranasal COVID vaccines. Not only are these vaccines delivered differently – but they also target a different part of our immune system.
The direct effects of COVID-19 disease on pregnant women, newborns and children are acknowledged. But the indirect effects of the pandemic have been equally devastating.
Your blood can hold a record of past illnesses. That information can reveal how many people have had a certain infection – like 58% of Americans having had COVID-19 by the end of February 2022.
Over 800 sites across the US report coronavirus data from sewage to the CDC. Here’s how this kind of surveillance system works and what it can and can’t tell you.
Vaibhav Upadhyay, University of Colorado Anschutz Medical Campus and Krishna Mallela, University of Colorado Anschutz Medical Campus
Existing coronavirus vaccines are not as effective against newer variants of the virus. Two vaccine experts explain how new vaccines currently in development will likely offer better protection.
Despite the halt to the federal mask mandate for mass transit, people may still choose to protect themselves. For those who do, the type of mask and how well it fits matter.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand